Methylene Blue
Methylthioninium chloride
Methylene Blue (Methylthioninium chloride) is a cognitive & mood research compound. Acts as an alternative mitochondrial electron carrier (boosts ATP) and antioxidant; nootropic at low doses. Note: it's an MAOI at higher doses — serotonergic-interaction caution.
Methylene Blue quick facts
| Reported research dose | 5mg-20mg |
| Route | Oral |
| Frequency | 1x Daily AM · 5 On 2 Off or Daily |
| Half-life | ~5–6 hrs |
| Forms | Oral |
| Evidence level | Human (clinical uses) + nootropic interest |
Low-dose only, and know the MAOI interaction if you're on any serotonergic meds. Respect it.
How Methylene Blue works
Acts as an alternative mitochondrial electron carrier (boosts ATP) and antioxidant; nootropic at low doses. Note: it's an MAOI at higher doses — serotonergic-interaction caution.
Proposed benefits
Low-dose mitochondrial ATP and antioxidant/nootropic support.
✅ Clinically validated
- An approved drug with over a century of use — it is first-line treatment for methaemoglobinaemia, with unambiguous clinical evidence, and is used as a surgical dye and in ifosfamide-induced encephalopathy.
- Cognitive and psychiatric trials exist and are small: work in bipolar depression and in memory tasks has reported benefit at low doses, but nothing approaching an approval-grade dataset.
📊 Correlative data
- Wide community use at low doses for cognitive and mitochondrial goals. Blue or green urine is universal and harmless. The consistently reported serious interaction is with serotonergic drugs.
🧪 Theoretical / extrapolated
- At low concentrations it acts as an alternative electron carrier in the mitochondrial transport chain, accepting electrons and donating them to cytochrome c — bypassing damaged complexes. At high concentrations it reverses and becomes a pro-oxidant.
- That hormetic dose-response is the whole story: the dose determines the direction of the effect, not just its size. It is also a potent MAO-A inhibitor, which is why the serotonin-syndrome risk with SSRIs is real and documented rather than theoretical.
These tiers tell you how much human evidence exists — not how well something works. This is the research space, and most of what’s in here is new rather than disproven. Something sitting at “theoretical” usually means nobody has funded the trial, not that the trial was run and failed.
The trap runs the other way too: something can be clinically validated and still do very little for you specifically. A statistically significant result in a study population is not a promise about your body.
- ✅ Clinically validated — human randomised trials or meta-analyses support it. The strongest footing available.
- 📊 Correlative — observational or epidemiological data. Suggestive, and genuinely useful for direction, but it cannot establish cause.
- 🧪 Theoretical / mechanistic — the mechanism is understood and often demonstrated in cells or animals, and the human trial doesn’t exist yet. Unproven is not the same as ineffective. Plenty of what’s standard practice today sat here five years ago.
✗ is a safety flag, not a grade. Where you see it, the concern is harm — not a disappointing trial. A compound tested for one purpose and found not to help there can still be worth studying somewhere else, so a negative result never gets rendered as a cross. It sits alongside the tier, because something can be both well-studied and genuinely risky.
My job is to tell you which one you’re looking at, and let you make the call. Grading something low isn’t me dismissing it — it’s me refusing to oversell it. This is the research space, and being able to reason forward from a mechanism matters as much as waiting for the trial.
Methylene Blue — safety, predicted from mechanism
Much of this compound class has never been through a human safety trial. Rather than say nothing — or print a generic warning — this is what its known mechanism predicts could go wrong, and what you can do about it. Predictions are labelled as predictions.
What the mechanism predicts
Derived from what this molecule does, not from a trial.
- This class is broad, but the predicted problems cluster by mechanism rather than by molecule. Cholinergics (racetams, and anything raising acetylcholine) predict headache — the classic one, from choline demand outrunning supply. Dopaminergics and eugeroics predict tolerance, sleep disruption and a flat mood on the days off. Anything glutamatergic or AMPA-facing carries a theoretical excitotoxicity concern at high doses.
- The pattern worth internalising: anything that borrows performance from tomorrow eventually presents the bill. Sleep is the most common currency it gets paid in.
What has actually been reported
- Headache is the most reported effect across the racetam family and usually responds to added choline.
- Irritability, blunted affect and a rebound low on cessation are commonly reported with the stimulant-adjacent members.
- Most of this class has little or no controlled human safety data at the doses actually used.
How to reduce the risk
Each of these follows from the same mechanism as the prediction.
- Take a choline source with any racetam. The headache is the mechanism running out of substrate, and it is largely preventable rather than something to push through.
- Dose in the morning. Almost everything in this class has a longer functional tail than its half-life suggests, and sleep is the first thing you lose.
- Use them for something, not as a habit. The compounds that carry tolerance genuinely reward intermittent use aimed at a task, and genuinely punish daily use aimed at feeling normal.
- One at a time, and long enough to judge it. This is the class where people stack five and cannot tell you which one is doing anything — and the effects are subjective, so attribution is already hard enough.
- If you need it to feel normal, stop. That is the line where a tool has become a dependency, and it is the one worth watching for.
What it does to your bloodwork
A fact about the assay, not a guess about the drug.
- No routine marker tracks these. Sleep is the assay — if it is degrading, the compound is costing more than it is producing, and that shows up before anything else does.
Don't run this if
- A seizure history — several of these lower the threshold at least theoretically, and it is not worth establishing empirically.
- Bipolar disorder, for the dopaminergic members especially.
- Alongside prescribed psychiatric medication without knowing exactly how the mechanisms overlap.
The honest unknown
- Chronic use is essentially uncharacterised. The specific unmeasured thing is what daily cholinergic or dopaminergic pressure does to baseline function over years — not whether a few weeks is tolerable.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this with a pharmacist or doctor.
Where to get Methylene Blue
Buy Methylene Blue at Ion Peptide →Methylene Blue — interference & stacking
Predicted from mechanism, not from an interaction study. There are no trials of these combinations — what follows is what the biology implies, so treat it as a reason to watch something, not as a finding.
What Methylene Blue moves on your bloodwork
These are the markers this compound is expected to move, and which direction. Knowing that in advance is mostly about NOT panicking: some of these moving is the compound working.
- hs-CRP (High-Sensitivity C-Reactive Protein) — ↓ expected to fall
Where these work, systemic inflammation is the plausible readout.
What to do: hs-CRP is cheap and moves. Baseline and 12 weeks. - HbA1c (Hemoglobin A1c) — ↓ expected to fall
Improved mitochondrial and metabolic function should show here if the effect is real at all.
What to do: The honest use of these markers is as a falsification test: if nothing moves in 12 weeks, the compound is not doing much for you. - Comprehensive Metabolic Panel (CMP) — ◆ worth watching
Liver and kidney function — the standard baseline for anything run long term.
What to do: Twice a year is enough on a stable protocol.
- Which compounds push the same lever, and why the dose adds up faster than people count
- What blunts it — the stacks that waste your money
- What compounds the risk, so a side effect arrives sooner than any one of them suggests
- Coach Cam's read on running it alongside the rest of your protocol
Get the complete breakdown for Methylene Blue — inside the Academy alongside the full interactive Vault.
Unlock in the Academy — $10/mo →This class is where honest expectation-setting matters most: the markers above are how you find out whether anything happened, and for most of these compounds that question is genuinely open.
- How to work up to it, and when not to
- When to take it, and why that window
- Cycle length
- Time off between cycles
- Fasted or fed, and when in the day
- Coach Cam's personal notes
Get the complete breakdown for Methylene Blue — inside the Academy alongside the full interactive Vault.
Unlock in the Academy — $10/mo →Bloodwork to run alongside Methylene Blue
Run these before you start, and again after 8–12 weeks. A baseline you didn’t take is one you can never go back for.
| Marker | What it’s watching for |
|---|---|
| Complete Blood Count (CBC) with Differential | In G6PD deficiency methylene blue causes haemolysis. Check before, not after |
| Comprehensive Metabolic Panel (CMP) | Liver and kidney baseline |
| hs-CRP (High-Sensitivity C-Reactive Protein) | General inflammatory baseline |
The The Basics — Start Here panel covers these in one order — 4 markers, $32.40 with the discount applied.
Check results you already have → · All 102 markers A–Z
Methylene Blue — frequently asked questions
What is Methylene Blue?
Methylene Blue (Methylthioninium chloride) is a cognitive & mood research compound. Acts as an alternative mitochondrial electron carrier (boosts ATP) and antioxidant; nootropic at low doses. Note: it's an MAOI at higher doses — serotonergic-interaction caution.
Is the full Methylene Blue protocol on this page?
The reported research dose is on this page, along with how Methylene Blue works and the evidence behind it. The protocol — how to work up to it, frequency, cycle length, time off, what not to stack it with and Coach Cam's notes — is inside the Academy.
What is the half-life of Methylene Blue?
Methylene Blue has an approximate half-life of ~5–6 hrs, which is part of what determines how often it's dosed.
What's the evidence behind Methylene Blue?
Current evidence level: Human (clinical uses) + nootropic interest. Methylene Blue is offered for research purposes only and is not an approved medicine.
Want Coach Cam's exact Methylene Blue protocol?
Dosing schedules, stacking, cycle timing and my personal notes live inside the Academy — plus the full interactive Vault of 237 compounds & 350 supplements.
Join the Academy — $10/mo →What Methylene Blue is used for
Methylene Blue appears under 4 goals in the Vault’s goal router, grouped by the mechanism it works through rather than by how much trial evidence exists. Each link opens that pathway in full, with the alternatives beside it and the bloodwork that tests it.